Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666705 · ClinicalTrials.gov registry record · Phase 4
A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects
A Phase 4 study, sponsored by ViiV Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT00666705 is a Phase 4 study that has completed, run by ViiV Healthcare. The registered enrollment target is 18 participants.
The verdict
NCT00666705, a Phase 4 study, has completed, sponsored by ViiV Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.
Interventions
- DRUG Maraviroc
- DRUG Raltegravir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00666705
The ClinicalTrials.gov registry entry for NCT00666705 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Maraviroc is the first listed.
NCT00666705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00666705 about?
NCT00666705 is a clinical study titled "A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects". An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.
What is the current status of trial NCT00666705?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2008-02. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00666705?
The interventions under investigation include: Maraviroc (DRUG), Raltegravir (DRUG).
Who is sponsoring clinical trial NCT00666705?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.